Rhea Williams is the Vice President of Regulatory Affairs at Castle Creek Biosciences, Inc. Ms. Williams has over 30 years of experience in regulatory affairs, quality assurance and pharmaceutical development.
She previously served as Vice President of Regulatory Affairs and Quality Assurance at Skye Bioscience, Inc. Ms. Williams has also held management positions at Johnson & Johnson, Schering-Plough and Eisai Inc., in addition to having supported large and small companies as founder and principal consultant of Secord Inc.
Throughout her career, Ms. Williams supported approvals for small and large molecules, working with teams focused on serious and life-threatening diseases as well as development of treatments in the areas of neurology, hematology, oncology, dermatology and women’s health.
She earned her master’s degree in Public Health from Columbia University and her bachelor’s degree in Psychology from the University of Pennsylvania.
